| Cvs Pharmacy # 03632 | |
| 5391 N Socrum Loop Rd, Lakeland, Florida 33809 | |
| (863) 858-6001 |
| Name | Cvs Pharmacy # 03632 |
|---|---|
| Organization Name | Holiday Cvs Llc |
| Location | 5391 N Socrum Loop Rd, Lakeland, Florida 33809 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (863) 858-6001 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cardiologists failed to identify more than half of basic and about 35 percent of advanced pre-recorded murmurs, but skills improved after a 90 minute training session, according to research presented today at the European Society of Cardiology Congress 2015.
Minority children and teenagers have fewer opportunities than white counterparts to be healthy, obtain a quality education and achieve economic success, according to a national survey of adults whose jobs involve children's education, health and economic well-being. The groundbreaking poll was released yesterday by the W. K. Kellogg Foundation, which sought to gauge the level of disparities affecting children of color.
Researchers have discovered a key to the function of a specific protein that helps control the levels of other critical proteins within cells, including a protein that suppresses the spread of cancer. The new information about the mechanism of action of the protein, called gp78, may enable researchers to explore new types of therapies to prevent the spread of cancer. The study, by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, was published in the June 26, 2009, issue of Molecular Cell.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1.5 million from the Foundation Fighting Blindness to fund a pre-clinical trial evaluating the safety and efficacy of a gene therapy treatment for X-linked Retinoschisis (XLRS), a genetic eye disease affecting over 35,000 patients in the US and Europe.
Continued research and new policies and practices to ensure proper use and disposal of foam and plastic products that contain potentially harmful flame retardant chemicals are needed to minimize health risks from environmental exposure to humans and animals.
› Verified 1 days ago
| NPI Number | 1750485603 |
| Organization Name | HOLIDAY CVS LLC |
| Doing Business As | CVS PHARMACY 03632 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5391 N Socrum Loop Rd, Lakeland, FL 33809 |
| Phone Number | 863-858-6001 |
News Archive
Cardiologists failed to identify more than half of basic and about 35 percent of advanced pre-recorded murmurs, but skills improved after a 90 minute training session, according to research presented today at the European Society of Cardiology Congress 2015.
Minority children and teenagers have fewer opportunities than white counterparts to be healthy, obtain a quality education and achieve economic success, according to a national survey of adults whose jobs involve children's education, health and economic well-being. The groundbreaking poll was released yesterday by the W. K. Kellogg Foundation, which sought to gauge the level of disparities affecting children of color.
Researchers have discovered a key to the function of a specific protein that helps control the levels of other critical proteins within cells, including a protein that suppresses the spread of cancer. The new information about the mechanism of action of the protein, called gp78, may enable researchers to explore new types of therapies to prevent the spread of cancer. The study, by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, was published in the June 26, 2009, issue of Molecular Cell.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1.5 million from the Foundation Fighting Blindness to fund a pre-clinical trial evaluating the safety and efficacy of a gene therapy treatment for X-linked Retinoschisis (XLRS), a genetic eye disease affecting over 35,000 patients in the US and Europe.
Continued research and new policies and practices to ensure proper use and disposal of foam and plastic products that contain potentially harmful flame retardant chemicals are needed to minimize health risks from environmental exposure to humans and animals.
› Verified 1 days ago
News Archive
Cardiologists failed to identify more than half of basic and about 35 percent of advanced pre-recorded murmurs, but skills improved after a 90 minute training session, according to research presented today at the European Society of Cardiology Congress 2015.
Minority children and teenagers have fewer opportunities than white counterparts to be healthy, obtain a quality education and achieve economic success, according to a national survey of adults whose jobs involve children's education, health and economic well-being. The groundbreaking poll was released yesterday by the W. K. Kellogg Foundation, which sought to gauge the level of disparities affecting children of color.
Researchers have discovered a key to the function of a specific protein that helps control the levels of other critical proteins within cells, including a protein that suppresses the spread of cancer. The new information about the mechanism of action of the protein, called gp78, may enable researchers to explore new types of therapies to prevent the spread of cancer. The study, by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, was published in the June 26, 2009, issue of Molecular Cell.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1.5 million from the Foundation Fighting Blindness to fund a pre-clinical trial evaluating the safety and efficacy of a gene therapy treatment for X-linked Retinoschisis (XLRS), a genetic eye disease affecting over 35,000 patients in the US and Europe.
Continued research and new policies and practices to ensure proper use and disposal of foam and plastic products that contain potentially harmful flame retardant chemicals are needed to minimize health risks from environmental exposure to humans and animals.
› Verified 1 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2325 Commerce Point Dr, Lakeland, Florida 33801 Phone: (863) 665-0308 | |
Publix Pharmacy #1171 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5185 Us Highway 98 S, Lakeland, Florida 33812 Phone: (863) 644-7969 | |
Cvs Pharmacy # 03632 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5391 N Socrum Loop Rd, Lakeland, Florida 33809 Phone: (863) 858-6001 | |
Cvs Pharmacy # 04801 Type: Pharmacy Location: 6170 Lakeland Highlands Rd, Lakeland, Florida 33813 Phone: (863) 619-6409 | |
Cvs Pharmacy #00304 Type: Pharmacy Location: 101 N Wabash Ave, Lakeland, Florida 33815 Phone: (863) 686-3131 |